Taysha Gene Therapies
TSHA
TSHA
130 hedge funds and large institutions have $290M invested in Taysha Gene Therapies in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.12% more ownership
Funds ownership: 76.6% → 81.71% (+5.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $316M → $290M (-$25.8M)
Holders
130
Holding in Top 10
1
Calls
$182K
Puts
$13K
Top Buyers
| 1 | +$20.7M | |
| 2 | +$12.2M | |
| 3 | +$10.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.23M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$3.57M |
Top Sellers
| 1 | -$13M | |
| 2 | -$12M | |
| 3 | -$5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.39M |